Related Experiment Video
Updated: Nov 11, 2025
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
835
Long Non-Coding RNAs: Role in Testicular Cancers.
Chiara Bresesti1,2, Valeria Vezzoli1,2, Biagio Cangiano1,2,3
1Department of Endocrine and Metabolic Medicine, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Frontiers in Oncology
|March 26, 2021
Summary
Long non-coding RNAs (lncRNAs) show promise in understanding and treating testicular cancer. Research into lncRNAs could lead to novel biomarkers and therapies, improving patient outcomes and reducing treatment side effects.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in various physiological and pathological processes.
- lncRNAs are implicated in tumor initiation, progression, and treatment response, attracting significant interest in oncology.
- Testicular cancer is a malignancy where the role of lncRNAs is beginning to be understood.
Purpose of the Study:
- To investigate the impact of lncRNAs in testicular cancer tumorigenesis.
- To explore the potential clinical applications of lncRNAs in managing testicular cancer.
- To identify lncRNAs as potential biomarkers, drug targets, or therapeutics for testicular cancer.
Main Methods:
- Literature review on lncRNA functions in cancer.
- Analysis of existing studies on lncRNAs in testicular cancer.
- Exploration of potential therapeutic strategies involving lncRNAs.
Main Results:
- lncRNAs play a significant role in the development and progression of testicular cancer.
- lncRNAs offer potential as biomarkers for early detection and prognosis.
- lncRNAs may serve as targets for novel therapeutic interventions.
Conclusions:
- Understanding lncRNA involvement in testicular cancer is crucial for developing new clinical strategies.
- lncRNAs present a promising avenue for alternative treatments with potentially fewer side effects than current therapies.
- The clinical application of lncRNAs could revolutionize the management of testicular cancer, including poor prognosis cases.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
9.3K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.3K
02:39lncRNA - Long Non-coding RNAs
3.1K
3.1K
03:18Non-LTR Retrotransposons
12.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.5K
01:20Types of RNA
8.1K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
8.1K
01:22MicroRNAs
3.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
01:22MicroRNAs
22.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.9K